Error: Could not add to watchlist. X
+ Watchlist

Keryx Biopharmaceuticals Inc

KERX:US
NASDAQ CM
5.85
USD
0.13
2.17%
As of 1:55 PM EDT 3/28/2017
Open
6.01
Day Range
5.72 - 6.05
Volume
640,805
Previous Close
5.98
52Wk Range
4.03 - 7.80
1 Yr Return
28.13%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
6.01
Day Range
5.72 - 6.05
Volume
640,805
Previous Close
5.98
52Wk Range
4.03 - 7.80
1 Yr Return
28.13%
YTD Return
-0.17%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.50
Market Cap (m USD)
627.763
Shares Outstanding (m)
107.678
Price/Sales (TTM)
19.30
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.02%
% Price Change
-0.02%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.
Address
One Marina Park Drive
Twelfth Floor
Boston, MA 02210
United States
Phone
1-617-466-3500
Show More